Please use this identifier to cite or link to this item:
http://hdl.handle.net/10553/45831
| Title: | Evaluation of 2 trilostane protocols for the treatment of canine pituitary-dependent hyperadrenocorticism: Twice daily versus once daily | Authors: | Arenas, C. Melián Limiñana, Carlos Pérez-Alenza, M. D. |
UNESCO Clasification: | 310907 Patología | Keywords: | Cushing's Endocrine Internal medicine |
Issue Date: | 2013 | Publisher: | 0891-6640 | Journal: | Journal of Veterinary Internal Medicine | Abstract: | Trilostane is the drug of choice to treat pituitary-dependent hyperadrenocorticism (PDH) in dogs, but there is still controversy about which protocol best controls the clinical signs and results of adrenal functioning test. | URI: | http://hdl.handle.net/10553/45831 | ISSN: | 0891-6640 | DOI: | 10.1111/jvim.12207 | Source: | Journal of Veterinary Internal Medicine [ISSN 0891-6640], v. 27, p. 1478-1485 |
| Appears in Collections: | Artículos |
Items in accedaCRIS are protected by copyright, with all rights reserved, unless otherwise indicated.